Occasionally, I spend a morning listening to Supreme Court oral arguments because I’m interested in the case and uncertain of the outcome.
Not today. For better or worse, I really don’t think SCOTUS is going to second-guess FDA on Mifepristone, though I wouldn’t bet too much on it.